These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 22429674)
1. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma. Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674 [TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma. Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390 [TBL] [Abstract][Full Text] [Related]
3. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer. Cao X; Chen YZ; Luo RZ; Zhang L; Zhang SL; Zeng J; Jiang YC; Han YJ; Wen ZS Oncotarget; 2015 May; 6(13):11704-13. PubMed ID: 25868976 [TBL] [Abstract][Full Text] [Related]
4. High expression of p300 has an unfavorable impact on survival in resectable esophageal squamous cell carcinoma. Li Y; Yang HX; Luo RZ; Zhang Y; Li M; Wang X; Jia WH Ann Thorac Surg; 2011 May; 91(5):1531-8. PubMed ID: 21524463 [TBL] [Abstract][Full Text] [Related]
5. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206 [TBL] [Abstract][Full Text] [Related]
6. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma. Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008 [TBL] [Abstract][Full Text] [Related]
7. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964 [TBL] [Abstract][Full Text] [Related]
10. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma. Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer. Sharma R; Chattopadhyay TK; Mathur M; Ralhan R Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792 [TBL] [Abstract][Full Text] [Related]
12. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers. Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742 [TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma]. Zhang Y; Liu YP; Du K; Wang H; Wang XL Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219 [TBL] [Abstract][Full Text] [Related]
14. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma. Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352 [TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma. Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172 [TBL] [Abstract][Full Text] [Related]
16. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899 [TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865 [TBL] [Abstract][Full Text] [Related]
18. Positive transforming growth factor-β activated kinase-1 expression has an unfavorable impact on survival in T3N1-3M0 esophageal squamous cell carcinomas. Wen J; Hu Y; Luo KJ; Yang H; Zhang SS; Fu JH Ann Thorac Surg; 2013 Jan; 95(1):285-90. PubMed ID: 23272845 [TBL] [Abstract][Full Text] [Related]
19. PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma. Shigaki H; Baba Y; Watanabe M; Murata A; Ishimoto T; Iwatsuki M; Iwagami S; Nosho K; Baba H Clin Cancer Res; 2013 May; 19(9):2451-9. PubMed ID: 23532889 [TBL] [Abstract][Full Text] [Related]
20. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis. Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]